Coldstream Capital Management »

Eyepoint Pharmaceuticals shares owned by Coldstream Capital Management

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Coldstream Capital Management from 13F filings

Historical chart of Coldstream Capital Management investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Coldstream Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Coldstream Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $114 21 5.43

More positions owned by Coldstream Capital Management

Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Hdg Msci Eafe (HEFA)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Proshares Tr S&p Mdcp 400 Div (REGL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Apple (AAPL)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Vanguard Index Fds Large Cap Etf (VV)
Dimensional Etf Trust Us Large Cap Val (DFLV)

View all positions for Coldstream Capital Management

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
Adage Capital Partners GP
BlackRock
Federated Investors
Franklin Resources
Vanguard Group
TCG Crossover Management
Citadel Advisors
Paradigm Biocapital Advisors
OrbiMed Advisors
Geode Capital Management
Goldman Sachs Group
State Street Corporation
Essex Woodlands Health Ventures

View all funds holding Eyepoint Pharmaceuticals